Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]

Human malaria is a complex disease that can show a wide array of clinical outcomes, from asymptomatic carriage and chronic infection to acute disease presenting various life-threatening pathologies. The specific outcome of an infection is believed to be determined by a multifactorial interplay betwe...

Full description

Bibliographic Details
Main Authors: Mario Recker, Peter C Bull, Caroline O Buckee
Format: Article
Language:English
Published: F1000 Research Ltd 2018-07-01
Series:F1000Research
Online Access:https://f1000research.com/articles/7-1159/v1
id doaj-5a7a47a4c7064138b8190b3f0f9535a3
record_format Article
spelling doaj-5a7a47a4c7064138b8190b3f0f9535a32020-11-25T03:35:24ZengF1000 Research LtdF1000Research2046-14022018-07-01710.12688/f1000research.14991.116320Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]Mario Recker0Peter C Bull1Caroline O Buckee2Centre for Mathematics and the Environment, University of Exeter, Penryn Campus, Penryn, TR10 9FE, UKDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UKCenter for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USAHuman malaria is a complex disease that can show a wide array of clinical outcomes, from asymptomatic carriage and chronic infection to acute disease presenting various life-threatening pathologies. The specific outcome of an infection is believed to be determined by a multifactorial interplay between the host and the parasite but with a general trend toward disease attenuation with increasing prior exposure. Therefore, the main burden of malaria in a population can be understood as a function of transmission intensity, which itself is intricately linked to the prevalence of infected hosts and mosquito vectors, the distribution of infection outcomes, and the parasite population diversity. Predicting the long-term impact of malaria intervention measures therefore requires an in-depth understanding of how the parasite causes disease, how this relates to previous exposures, and how different infection pathologies contribute to parasite transmission. Here, we provide a brief overview of recent advances in the molecular epidemiology of clinical malaria and how these might prove to be influential in our fight against this important disease.https://f1000research.com/articles/7-1159/v1
collection DOAJ
language English
format Article
sources DOAJ
author Mario Recker
Peter C Bull
Caroline O Buckee
spellingShingle Mario Recker
Peter C Bull
Caroline O Buckee
Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
F1000Research
author_facet Mario Recker
Peter C Bull
Caroline O Buckee
author_sort Mario Recker
title Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
title_short Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
title_full Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
title_fullStr Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
title_full_unstemmed Recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
title_sort recent advances in the molecular epidemiology of clinical malaria [version 1; referees: 4 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2018-07-01
description Human malaria is a complex disease that can show a wide array of clinical outcomes, from asymptomatic carriage and chronic infection to acute disease presenting various life-threatening pathologies. The specific outcome of an infection is believed to be determined by a multifactorial interplay between the host and the parasite but with a general trend toward disease attenuation with increasing prior exposure. Therefore, the main burden of malaria in a population can be understood as a function of transmission intensity, which itself is intricately linked to the prevalence of infected hosts and mosquito vectors, the distribution of infection outcomes, and the parasite population diversity. Predicting the long-term impact of malaria intervention measures therefore requires an in-depth understanding of how the parasite causes disease, how this relates to previous exposures, and how different infection pathologies contribute to parasite transmission. Here, we provide a brief overview of recent advances in the molecular epidemiology of clinical malaria and how these might prove to be influential in our fight against this important disease.
url https://f1000research.com/articles/7-1159/v1
work_keys_str_mv AT mariorecker recentadvancesinthemolecularepidemiologyofclinicalmalariaversion1referees4approved
AT petercbull recentadvancesinthemolecularepidemiologyofclinicalmalariaversion1referees4approved
AT carolineobuckee recentadvancesinthemolecularepidemiologyofclinicalmalariaversion1referees4approved
_version_ 1724554597353127936